These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 24186136)

  • 21. Micropapillary urothelial carcinoma: evaluation of HER2 status and immunohistochemical characterization of the molecular subtype.
    Zinnall U; Weyerer V; Compérat E; Camparo P; Gaisa NT; Knuechel-Clarke R; Perren A; Lugli A; Toma M; Baretton G; Kristiansen G; Wirtz RM; Cheng L; Wullich B; Stoehr R; Hartmann A; Bertz S
    Hum Pathol; 2018 Oct; 80():55-64. PubMed ID: 29885409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serine threonine kinase 15 amplification in normal urothelium of cystectomy specimens is no prognostic factor in urothelial carcinoma of the bladder.
    Otto W; Fritsche HM; Wild PJ; Wieland WF; Hartmann A; Burger M; Hofstädter F; Denzinger S
    Pathol Res Pract; 2011 Mar; 207(3):161-3. PubMed ID: 21247708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Systematic Review and Meta-Analysis of Variant Histology in Urothelial Carcinoma of the Bladder Treated with Radical Cystectomy.
    Mori K; Abufaraj M; Mostafaei H; Quhal F; Karakiewicz PI; Briganti A; Kimura S; Egawa S; Shariat SF
    J Urol; 2020 Dec; 204(6):1129-1140. PubMed ID: 32716694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is Immediate Radical Cystectomy Necessary for All Patients with Non-Muscle-Invasive Micropapillary Bladder Cancer?
    Jackson BL; Mohammed A; Mayer N; Dormer J; Griffiths TR
    Urol Int; 2016; 96(1):32-8. PubMed ID: 25924623
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical comparison of MUC1, CA125, and Her2Neu in invasive micropapillary carcinoma of the urinary tract and typical invasive urothelial carcinoma with retraction artifact.
    Sangoi AR; Higgins JP; Rouse RV; Schneider AG; McKenney JK
    Mod Pathol; 2009 May; 22(5):660-7. PubMed ID: 19270645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downstaging to non-invasive urothelial carcinoma is associated with improved outcome following radical cystectomy for patients with cT2 disease.
    Tollefson MK; Boorjian SA; Farmer SA; Frank I
    World J Urol; 2012 Dec; 30(6):795-9. PubMed ID: 22447397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bladder Tumor Subtype Commitment Occurs in Carcinoma
    Wullweber A; Strick R; Lange F; Sikic D; Taubert H; Wach S; Wullich B; Bertz S; Weyerer V; Stoehr R; Breyer J; Burger M; Hartmann A; Strissel PL; Eckstein M
    Cancer Res; 2021 Mar; 81(6):1552-1566. PubMed ID: 33472889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Value of multicolour fluorescence in situ hybridisation (UroVysion) in the differential diagnosis of flat urothelial lesions.
    Schwarz S; Rechenmacher M; Filbeck T; Knuechel R; Blaszyk H; Hartmann A; Brockhoff G
    J Clin Pathol; 2008 Mar; 61(3):272-7. PubMed ID: 17693577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and progression of urothelial carcinoma.
    Kakizoe T
    Cancer Sci; 2006 Sep; 97(9):821-8. PubMed ID: 16822297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low level STK15 amplification in histologically benign urothelium of patients with bladder cancer adversely predicts patient outcome following cystectomy.
    Denzinger S; Stoehr R; Schwarz S; Eichenseher N; Brockhoff G; Obermann EC; Knuechel R; Blaszyk H; Hartmann A; Wild PJ
    Int J Oncol; 2007 Oct; 31(4):793-802. PubMed ID: 17786310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasmacytoid variant of bladder cancer defines patients with poor prognosis if treated with cystectomy and adjuvant cisplatin-based chemotherapy.
    Keck B; Wach S; Stoehr R; Kunath F; Bertz S; Lehmann J; Stöckle M; Taubert H; Wullich B; Hartmann A
    BMC Cancer; 2013 Feb; 13():71. PubMed ID: 23394492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Urothelial hyperplastic lesion with endophytic growth pattern: a clinicopathologic study].
    Xiao L; Wang CF; Zhu XZ; Yin YL; Chen Y; Lu C; Yu B
    Zhonghua Bing Li Xue Za Zhi; 2011 May; 40(5):319-23. PubMed ID: 21756826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Impact of Plasmacytoid Variant Histology on the Survival of Patients with Urothelial Carcinoma of Bladder after Radical Cystectomy.
    Li Q; Assel M; Benfante NE; Pietzak EJ; Herr HW; Donat M; Cha EK; Donahue TF; Bochner BH; Dalbagni G
    Eur Urol Focus; 2019 Jan; 5(1):104-108. PubMed ID: 28753857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance in substaging ofT1 urinary bladder urothelial carcinoma on transurethral resection.
    Chang WC; Chang YH; Pan CC
    Am J Surg Pathol; 2012 Mar; 36(3):454-61. PubMed ID: 22261706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HER2 Protein Overexpression and Gene Amplification in Plasmacytoid Urothelial Carcinoma of the Urinary Bladder.
    Kim B; Kim G; Song B; Lee C; Park JH; Moon KC
    Dis Markers; 2016; 2016():8463731. PubMed ID: 27034533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical outcome of patients with T1 micropapillary urothelial carcinoma of the bladder.
    Spaliviero M; Dalbagni G; Bochner BH; Poon BY; Huang H; Al-Ahmadie HA; Donahue TF; Taylor JM; Meeks JJ; Sjoberg DD; Donat SM; Reuter VE; Herr HW
    J Urol; 2014 Sep; 192(3):702-7. PubMed ID: 24603101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Noninvasive micropapillary urothelial carcinoma: a clinicopathologic study of 18 cases.
    Amin A; Epstein JI
    Hum Pathol; 2012 Dec; 43(12):2124-8. PubMed ID: 22939957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of histological variants on outcomes after open radical cystectomy for muscle-invasive urothelial bladder cancer: results from a single tertiary referral centre.
    Naspro R; Finati M; Roscigno M; Pellucchi F; La Croce G; Sodano M; Manica M; Chinaglia D; Da Pozzo LF
    World J Urol; 2021 Jun; 39(6):1917-1926. PubMed ID: 32696127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of squamous and glandular differentiation on survival after radical cystectomy for urothelial carcinoma.
    Kim SP; Frank I; Cheville JC; Thompson RH; Weight CJ; Thapa P; Boorjian SA
    J Urol; 2012 Aug; 188(2):405-9. PubMed ID: 22704101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterizing the Genomic Landscape of the Micropapillary Subtype of Urothelial Carcinoma of the Bladder Harboring Activating Extracellular Mutations of ERBB2.
    Posada JM; Yakirevich E; Kamat AM; Sood A; Jacob JM; Bratslavsky G; Grivas P; Spiess PE; Li R; Necchi A; Mega AE; Golijanin DJ; Pavlick D; Huang RSP; Lin D; Danziger N; Sokol ES; Sivakumar S; Ross JS; Cheng L
    Mod Pathol; 2024 Mar; 37(3):100424. PubMed ID: 38219954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.